ATE361360T1 - Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung - Google Patents

Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung

Info

Publication number
ATE361360T1
ATE361360T1 AT99922611T AT99922611T ATE361360T1 AT E361360 T1 ATE361360 T1 AT E361360T1 AT 99922611 T AT99922611 T AT 99922611T AT 99922611 T AT99922611 T AT 99922611T AT E361360 T1 ATE361360 T1 AT E361360T1
Authority
AT
Austria
Prior art keywords
cultivation
same
culture media
animal cells
producing proteins
Prior art date
Application number
AT99922611T
Other languages
English (en)
Inventor
Kazushi Shibuya
Masaru Atsumi
Shigeyuki Tsunakawa
Kaneo Chugai Nogaki
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE361360T1 publication Critical patent/ATE361360T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides or bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT99922611T 1998-06-01 1999-06-01 Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung ATE361360T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15095798 1998-06-01

Publications (1)

Publication Number Publication Date
ATE361360T1 true ATE361360T1 (de) 2007-05-15

Family

ID=15508136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922611T ATE361360T1 (de) 1998-06-01 1999-06-01 Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung

Country Status (15)

Country Link
US (2) US6537782B1 (de)
EP (1) EP1085083B1 (de)
JP (1) JP3510858B2 (de)
KR (1) KR100430447B1 (de)
CN (1) CN1187441C (de)
AT (1) ATE361360T1 (de)
AU (1) AU744715B2 (de)
CA (1) CA2333966C (de)
DE (1) DE69935978T2 (de)
DK (1) DK1085083T3 (de)
ES (1) ES2285840T3 (de)
IL (1) IL139974A (de)
NO (2) NO326180B1 (de)
RU (2) RU2214455C2 (de)
WO (1) WO1999063058A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2322216A1 (de) 1997-03-21 2011-05-18 Chugai Seiyaku Kabushiki Kaisha Präventives oder therapeutisches Mittel mit einem IL-6-Antagonisten als Wirkstoff für durch sensibilisierte T-Zellen vermittelte Erkrankungen
WO2001048147A1 (en) * 1999-12-28 2001-07-05 Iso Tis N.V. Cell culture medium containing growth factors and l-glutamine
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
DE10124820A1 (de) 2001-05-21 2002-12-05 Heinrich Wieland Zusammensetzung und Verwendung von Substanzen zur Stabilisierung von schwefelhaltigen Aminosäuren im Blut
CN101721362B (zh) * 2002-02-14 2018-07-03 中外制药株式会社 包含抗体的溶液制剂
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
WO2005090405A1 (ja) * 2004-03-24 2005-09-29 Chugai Seiyaku Kabushiki Kaisha インターロイキン－６受容体に対するヒト型化抗体のサブタイプ
US7335491B2 (en) * 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
KR100679112B1 (ko) * 2004-11-17 2007-02-07 삼성정밀화학 주식회사 동물세포 배양방법
EP1835022B1 (de) * 2005-01-05 2015-02-11 Chugai Seiyaku Kabushiki Kaisha Zellkulturverfahren und dessen nutzung
EP2495308A1 (de) 2005-12-08 2012-09-05 Amgen Inc. Verbesserte Herstellung von Glykoproteinen unter Verwendung von Mangan
ES2474573T3 (es) * 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos
PE20091174A1 (es) 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
SI2493922T1 (sl) 2009-10-26 2017-06-30 F. Hoffmann-La Roche Ag Postopek za proizvodnjo glikoziliranega imunoglobulina
MD191Z5 (ro) * 2010-01-21 2010-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Mediu nutritiv pentru cultivarea celulelor de origine animală
KR20190120439A (ko) 2010-11-08 2019-10-23 제넨테크, 인크. 피하 투여용 항―ｉｌ―6 수용체 항체
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
ES2782380T5 (es) 2013-10-30 2023-05-08 Univ Missouri Método de especificación y cultivo de linaje del músculo esquelético escalable
DK3305891T3 (da) 2015-05-27 2021-01-25 Astellas Pharma Inc Celledyrkningsfremgangsmåde som anvender nukleinsyre-holdigt medium
WO2017147169A1 (en) 2016-02-22 2017-08-31 Ohio State Innovation Foundation Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites
CN110603057A (zh) 2017-03-17 2019-12-20 俄亥俄州创新基金会 用于递送化学预防剂的纳米颗粒
WO2018208628A1 (en) 2017-05-06 2018-11-15 Memphis Meats, Inc. Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure
WO2019014652A1 (en) 2017-07-13 2019-01-17 Memphis Meats, Inc. COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF CELL CULTURES USED IN FOOD PRODUCTION
EP3947737A2 (de) 2019-04-02 2022-02-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren zur vorhersage und vorbeugung von krebs bei patienten mit prämalignen läsionen
WO2022137357A1 (ja) 2020-12-22 2022-06-30 株式会社マルハチ村松 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法
WO2023240152A1 (en) 2022-06-07 2023-12-14 Upside Foods, Inc. Engineering cell lines capable of proliferation in growth factor free media formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS509877B2 (de) * 1972-09-13 1975-04-16
US3962425A (en) * 1972-09-21 1976-06-08 Weyerhaeuser Company Ruminant repellent from enzymatically putrefied lipoidal material
JPS5336033B2 (de) * 1972-12-11 1978-09-30
JPH01148181A (ja) * 1987-12-07 1989-06-09 Jgc Corp グルタチオンの菌体内蓄積法
JPH0239882A (ja) * 1988-07-29 1990-02-08 Japan Synthetic Rubber Co Ltd 動物細胞培養用培地
JPH0638704A (ja) * 1991-06-19 1994-02-15 Morinaga Milk Ind Co Ltd 発酵調味料及びその製造法
US5426045A (en) * 1993-12-16 1995-06-20 Sea Run Holdings, Inc. Method for culturing mammalian cells in a medium containing fish serum
CA2183980A1 (en) 1994-02-23 1995-08-31 Evelyn S. Sawyer Method for culturing mammalian cells and insect cells in a medium containing fish serum
RU2103360C1 (ru) * 1996-07-25 1998-01-27 Инна Георгиевна Ермишина Питательная среда для культивирования клеток эукариотов и способ получения основы питательной среды - протеолитического гидролизата
CN1157694A (zh) 1996-10-15 1997-08-27 玉环县海天营养源有限公司 一种液化鱼蛋白粉的制作方法

Also Published As

Publication number Publication date
US20030096372A1 (en) 2003-05-22
EP1085083B1 (de) 2007-05-02
NO20006096L (no) 2001-02-01
IL139974A (en) 2005-09-25
CN1187441C (zh) 2005-02-02
US6962812B2 (en) 2005-11-08
AU744715C (en) 1999-12-20
RU2214455C2 (ru) 2003-10-20
DE69935978D1 (de) 2007-06-14
US6537782B1 (en) 2003-03-25
DK1085083T3 (da) 2007-06-18
ES2285840T3 (es) 2007-11-16
IL139974A0 (en) 2002-02-10
AU3958499A (en) 1999-12-20
AU744715B2 (en) 2002-02-28
RU2333242C2 (ru) 2008-09-10
KR20010071359A (ko) 2001-07-28
EP1085083A1 (de) 2001-03-21
CA2333966A1 (en) 1999-12-09
HK1037678A1 (en) 2002-02-15
JP3510858B2 (ja) 2004-03-29
WO1999063058A1 (en) 1999-12-09
NO2009012I1 (no) 2009-06-15
CA2333966C (en) 2006-07-25
NO326180B1 (no) 2008-10-13
NO20006096D0 (no) 2000-11-30
CN1309698A (zh) 2001-08-22
KR100430447B1 (ko) 2004-05-10
DE69935978T2 (de) 2008-01-17
EP1085083A4 (de) 2002-11-27

Similar Documents

Publication Publication Date Title
ATE361360T1 (de) Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung
ATE258189T1 (de) Verfahren zur herstellung von erythropoietin frei von tierischen proteinen
DE69030765D1 (de) Medien zur zellzucht und verfahren dazu
ATE213271T1 (de) Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte- fermentation
AU560340B2 (en) Rennin from recombinant dna
DE60335195D1 (de) Mutante e. coli-appa-phytaseenzyme und natürliche varianten davon, solche phytaseenzyme codierende nukleinsäuren, diese enthaltende vektoren und wirtszellen und verfahren zur herstellung und verwendung davon
PL374782A1 (en) Animal protein free media for cultivation of cells
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
DE602005008604D1 (de) Hydrolysiertes meeresproteinprodukt, verfahren zu seiner herstellung und verwendung
ATE521695T1 (de) Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie
ATE479743T1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
DE3485336D1 (de) Verfahren zur expression von alpha-1-antitrypsin in bakterien und dessen verwendung in therapeutischen zusammensetzungen sowie vektoren und bakterien fuer ein solches verfahren und deren herstellung.
WO2001042283A3 (en) Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
DE3575743D1 (de) Verfahren zur gewinnung von phenylalanin-dehydrogenase enthaltenden mikroorganismen und deren verwendung zur herstellung von l-alpha-aminosaeuren.
DE59606567D1 (de) Neuer Mikroorganismus, dessen Verwendung und Verfahren zur Herstellung von L-Alpha-Aminosäuren
ATE463501T1 (de) Verfahren und materialien zur herstellung und anwendung transgener, dicamba abbauender organismen
DE3678552D1 (de) Verfahren zur herstellung von proteinen unter verwendung von transformierten milchsaeurebakterien.
EP0756003A4 (de) Methode zur kultivierung von tierzellen
DE60025036D1 (de) Verfahren zur züchtung von haftenden tierischen zellen
DE69941789D1 (de) In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten
ATE384790T1 (de) Uroplakin-ii-promotor aus schwein und verfahren zur herstellung nützlicher proteine unter verwendung des promotors
ATE288476T1 (de) Herstellung von proteinen
ATE312195T1 (de) Verfahren zur herstellung von fremden proteinen
DE3673686D1 (de) Immobilisierte maltooligosaccharid-bildende amylase und verfahren zur herstellung von maltooligosaccharid unter verwendung des genannten enzyms.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1085083

Country of ref document: EP